Harvard Bioscience Inc.

Harvard Bioscience Inc., doing business as Data Sciences International, is a self-certified small disadvantaged business manufacturer of wireless implantable telemetry systems, physiological monitoring equipment, and data acquisition software that operates as a prime contractor delivering specialized biomedical research instrumentation to federal agencies on full-and-open (no set-aside) contracts. The company is headquartered in New Brighton, Minnesota with a subsidiary operating division in Mounds View, Minnesota and competes across 55 distinct federal customer agencies with a recent prime-only award footprint of 815 total contracts and IDVs spanning laboratory equipment, surgical supplies, and software solutions.

Harvard Bioscience's customer concentration is heavily weighted toward defense medical research. The Department of the Army Medical Command dominates both award count and dollar value, accounting for 278 awards (34% of the tracked portfolio) with $52.5 million in combined potential value—more than five times the next-ranked customer. The Defense Health Agency follows with 51 awards and $8.6 million, while the FDA, National Institute on Drug Abuse, and EPA's Office of Research and Development collectively represent the next tier of civilian research demand. This concentration reflects the vendor's core strength in supplying telemetry implants, pre-implanted research animals (ferrets, rats, mice, non-human primates), and surgical implantation services to defense and military health sector research programs.

The vendor's dominant vehicle position flows through the Defense Health Agency's $4.847 million single-award Blanket Purchase Agreement established May 4, 2022, and expiring May 3, 2027, which has generated cumulative task order value exceeding $1.5 million with individual call orders ranging from approximately $8,320 to $235,556. The Army Medical Command issues the majority of these task orders. Beyond that anchor BPA, the vendor holds positions on multiple Army-issued indefinite delivery vehicles, including BPA W81XWH16A0013 (73 task orders, $5.8 million), BPA W81XWH22A0001 (57 task orders, $4.1 million), and IDCs W81XWH09D0026 and W81XWH13D0003, collectively demonstrating sustained demand for telemetry and physiological monitoring solutions across military medical research operations.

Recent representative prime work illustrates the vendor's core capability set. A $242.9 million USDA Agricultural Research Service purchase order awarded September 2025 for large and small animal telemetry implants, physiologic monitoring devices, software, and training at the National Bio and Agro Defense Facility in Manhattan, Kansas, was set aside for total small business. A $332 thousand VA Veterans Integrated Service Network purchase order (July 2023) procured a complete DSI Ponemah telemetry system as sole-source due to OEM compatibility lock-in. A $158.7 million NIAID award (April 2022) for COVID-19 small animal telemetry systems for measuring vital signs in infected mice demonstrates the vendor's responsiveness to urgent federal health research priorities. A $145.9 million NIEHS purchase order (July 2024) for DSI wireless telemetry mouse implants and a $132.8 million NIH Clinical Center contract (May 2024) for Ponemah software, testing, and installation services show breadth across civilian biomedical research agencies.

Activity declined year over year from 27 awards in 2022 to eight year-to-date through late 2026, though cumulative potential value remains substantial at $74.9 million across all tracked awards. Four awards face ultimate completion within the next twenty-four months with combined potential value of $924 thousand, representing modest recompete exposure. The vendor's NAICS footprint is concentrated in analytical laboratory instrument manufacturing (292 awards) and surgical appliance and supplies manufacturing (139 awards), with secondary exposure in custom programming and IT services reflecting the software-enabled nature of modern telemetry data acquisition.

Harvard Bioscience operates as a fully prime organization; the source records four sub-awards but these represent nominal activity. The vendor's federal performance occurs across multiple locations including Mounds View, Minnesota (primary manufacturing and software); Aberdeen Proving Ground, Maryland (surgical implantation services); San Antonio, Texas (JBSA Fort Sam Houston); and Frederick, Maryland, with placement of performance matching the geographically distributed network of military medical research facilities. The parent company structure—Harvard Bioscience Inc. as the corporate entity with Data Sciences International as the operating division—is relevant for vendor identification but does not signal material subsidiary diversification or separate contracting streams within this federal footprint.